EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment

Pratibha Pandey iD, Fahad Khan iD, Tarun Kumar Upadhyay iD, Amit Baran Sharangi iD

International Journal of Molecular Sciences · 23.01.2023 · 24 (3) · 2236

DOI: 10.3390/ijms24032236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2023. Verfasst von Pratibha Pandey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is characterized by persistent cell proliferation driven by aberrant cell cycle regulation and stimulation of cyclin-dependent kinases (CDKs). A very intriguing and potential approach for the development of antitumor medicines is the suppression of CDKs that lead to induction of apoptosis and cell cycle arrest. The shift of the cell cycle from the G0/G1 phase to the S phase, which is characterized by active transcription and synthesis, depends on the development of the cyclin D-CDK4/6 complex. A precise balance between anticancer activity and general toxicity is demonstrated by CDK inhibitors, which can specifically block CDK4/6 and control the cell cycle by reducing the G1 to S phase transition. CDK4/6 inhibitors have recently been reported to exhibit significant cell growth inhibition via modulating the tumour microenvironment in cancerous cells. One significant new understanding is that these inhibitors serve important functions in the interaction among tumour cells and the host immune system in addition to being cytostatic. Herein, we discuss the biological significance of CDK4/6 inhibitors in cancer therapeutics, as well as their biological impact on T cells and other important immune cells. Furthermore, we explore the integration of preclinical findings of these pharmaceuticals’ ability to enhance antitumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTumor MicroenvironmentHumansCell CycleCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Serine-Threonine Kinases

Stichwörter der Autor:innen

CDK4CDK6cancer therapycell cycleimmunotherapytumor microenvironment

Substanzen

CDK4 protein, humanCDK6 protein, humanCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India.
  • Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India.
  • Department of Plantation Spices Medicinal and Aromatic Crops, Bidhan Chandra Krishi Viswavidyalaya, Mohanpur 741252, India.

ORCID-Profile: Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, Amit Baran Sharangi

Zitieren

APA

Pandey, P., Khan, F., Upadhyay, T. K., & Sharangi, A. B. (2023). Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment. International Journal of Molecular Sciences, 24(3), 2236. https://doi.org/10.3390/ijms24032236

Vancouver

Pandey P, Khan F, Upadhyay TK, Sharangi AB. Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment. International Journal of Molecular Sciences. 2023;24(3):2236. doi:10.3390/ijms24032236

BibTeX
@article{Pandey2023,
  author = {Pandey, Pratibha and Khan, Fahad and Upadhyay, Tarun Kumar and Sharangi, Amit Baran},
  title = {Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2236},
  doi = {10.3390/ijms24032236}
}
Kostenlos starten →